Approved by the Drug Controller General of India (DCGI), the treatment offers to slow disease progression and promote ...

Cipla and Stempeutics launch Ciplostem, a DCGI-approved cell therapy for Grade II–III Knee Osteoarthritis, offering long-term ...

Cipla partners with Stempeutics to launch Ciplostem, a new therapy for Knee Osteoarthritis approved by DCGI. Targets disease ...

An Osaka Metropolitan University-led research team found that patients with knee osteoarthritis show a weaker human-body ...

Cold weather intensifies joint pain for Osteoarthritis sufferers due to reduced blood flow. While OA is irreversible, ...

Pilot program addresses critical evidence gap in emerging regenerative medicine treatments for 32.5 million Americans with ...

Osteoarthritis (OA), the most prevalent musculoskeletal disease in India, affects over 62 million people, with a prevalence ...

Pacira BioSciences PCRX announced results from a pilot study evaluating the unique therapeutic approach of its iovera system ...

Infosys, Pine Labs, ONGC, Bank of Maharashtra, Tata Capital, Lemon Tree Hotels, Vintage Coffee are among the top stocks to ...

The Oregon Ducks are expected to be without their top pass-catchers for Saturday's game against the Washington Huskies.